Sustchem Techniki Symvouleftiki
Sustchem Techniki Symvouleftiki is recorded as a service provider in 3 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 3 of 3 trials · Latest update first
Safety and efficacy of anakinra treatment for patients with persistent respiratory symptoms post acute covid and immune system activation: the PRECISION double-blind, randomized clinical trial
Sponsor Hellenic Institute For The Study Of Sepsis
- Start (EU)
- Latest update
- Estimated end
- Not reported
Biomarker-Guided Early Clarithromycin Treatment To Prevent Sepsis Progression In Community-Acquired Pneumonia: The REACT Randomized Clinical Trial
Sponsor Hellenic Institute For The Study Of Sepsis
- Start (EU)
- Latest update
- Estimated end
- Not reported
A RANDOMIZED PROSPECTIVE CLINICAL TRIAL TO ASSESS PROCALCITONIN-GUIDANCE AND MOLECULAR-GUIDED DIAGNOSIS AS MAINSTAY FOR THERAPY OF SEVERE INFECTIONS (The MODIFY trial)
Sponsor Hellenic Institute For The Study Of Sepsis
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Sustchem Techniki Symvouleftiki?
The 2026-10-09 snapshot links Sustchem Techniki Symvouleftiki to 3 distinct CTIS trials. Recorded services include Safety reporting & pharmacovigilance. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Sustchem Techniki Symvouleftiki?
Therapeutic-area tags are not recorded in this snapshot. Study-phase tags are not recorded. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Sustchem Techniki Symvouleftiki conducted?
The linked trials record locations in 4 countries, including Greece, Germany, Spain, Italy. These are trial locations, not confirmed office locations or countries where Sustchem Techniki Symvouleftiki delivered services.
What can this page tell me about Sustchem Techniki Symvouleftiki's trial experience?
Browse 3 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Sustchem Techniki Symvouleftiki. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Sustchem Techniki Symvouleftiki S.A.